Overexpressed CD55 leads to a poor outcome in certain cancers (Durrant et al., 2003[9]), additionally, human cSCC cells also show resistance to complement lysis due to the presence of CD55 (Whitlow and Klein, 1997[38]). Here, CD55 is linked to cancer.